POSTED BY ISABEL TEARE | 27 OCTOBER 2020 UK will access new regulatory partnerships from the start of 2021 Members of the European Union operate closely coordinated medicines approval systems, with innovative products coming within the remit of the EMEA for central approval. Read more Share this article Bookmark this page 1 min read Brexit Clinical trials Personalised medicine Pharmaceutical regulation
POSTED BY ISABEL TEARE | 6 OCTOBER 2020 CRISPR pioneers awarded Nobel Prize We are delighted to learn of the The Royal Swedish Academy of Sciences to give the 2020 Nobel Prize in Chemistry to Emmanuelle Charpentier and Jennifer A. Doudna. Share this article Bookmark this page 1 min read
POSTED BY ISABEL TEARE | 1 OCTOBER 2020 The UK life sciences market after December 2020 – clinical trials UK Government has issued new Brexit guidance for the life sciences sector. With the transition period coming to an end on 31 December, only three months remain before the Medicines and Healthcare products Regulatory Agency (MHRA) takes on... Share this article Bookmark this page 2 min read
POSTED BY ISABEL TEARE | 10 SEPTEMBER 2020 The UK life sciences market after December 2020 - licensing of medicinal products In this article, we take a look at the guidance on licensing of medicines and related products, particularly marketing authorisations. This addresses the following topics... Share this article Bookmark this page 3 min read
POSTED BY ISABEL TEARE | 3 SEPTEMBER 2020 The UK life sciences market after December 2020 - medical devices In this article, we discuss the future for medical devices. Producers of medical devices will face major changes after the end of the transition period. Share this article Bookmark this page 2 min read
POSTED BY ISABEL TEARE | 17 AUGUST 2020 Enhancements to the LCIA arbitration rules The COVID-19 pandemic is leading to an unusual level of disputes between commercial partners. It is also putting serious strain on court resources. Many contracting parties are turning to alternative methods of dispute resolution, with arbitration being a good choice for many. Share this article Bookmark this page 1 min read
POSTED BY ISABEL TEARE | 12 AUGUST 2020 Guidance on data privacy compliance for AI developers Artificial Intelligence (AI) technology is advancing at a rapid pace, and playing an increasing role in drug discovery and healthcare. AI is being used to assist with early detection of diseases, including cancer, diagnosis, treatment, and in keeping us well. Share this article Bookmark this page 1 min read
POSTED BY ALEX RUSSELL | 9 AUGUST 2020 New immigration system – key points for the life sciences and technology sectors The Government has published further details about the new immigration system that is due to be implemented from 1 January 2021. Share this article Bookmark this page 5 min read
POSTED BY ISABEL TEARE | 21 JULY 2020 What next for Europe’s unitary patent plans? Many had thought that the combination of the UK’s withdrawal and the negative ruling of the German Constitutional Court in March had stopped this long-standing initiative in its tracks. Both the UK and Germany had central roles in the Unified Patent Court, and are essential to the ratification of the UPC Agreement. Share this article Bookmark this page 2 min read
POSTED BY ISABEL TEARE | 20 JULY 2020 The demise of Privacy Shield ... At the end of last week, the European Court of Justice (CJEU) provided the 'Schrems II’ judgment. It is something which is already causing widespread shudders - not only for those involved in transferring personal data... Share this article Bookmark this page 5 min read
Subscribe Receive blog alerts via email from our leading team of legal experts Register Visitor Login